Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-12

Clinical Trial Update: Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS [Phase 3]

View source ↗

Summary

Phase 3 placebo-controlled trial evaluating the efficacy and safety of Injectafer for Restless Legs Syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INJECTAFER (ferric carboxymaltose injection)

Snippet

Sponsor: American Regent, Inc. | Conditions: Restless Legs Syndrome (RLS) | Phase 3 | Status: COMPLETED | Results posted: 2021-10-12